Targacept Announces Participation in Upcoming Conferences

[at noodls] – Winston-Salem, NC April 22, 2013 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeuticsâ„¢, today announced that Dr. Stephen A. Hill, President and Chief … more

View todays social media effects on TRGT

View the latest stocks trending across Twitter. Click to view dashboard

See who Targacept is hiring next, click here to view